Table 2.
Cosinor Regression Statistic | Sham (n = 14) | TRDNx (n = 16) | ARDNx (n = 16) |
---|---|---|---|
Protocol day −1 | |||
MESOR, mmHg | 157.0 ± 0.9 | 162.3 ± 0.8 | 156.9 ± 0.8 |
Amplitude, mmHg | 11.4 ± 1.3 | 10.7 ± 0.9 | 9.7 ± 1.1 |
Acrophase, h | 19.3 ± 0.3 | 19.8 ± 0.6 | 19.3 ± 0.3 |
Protocol day 14 | |||
MESOR, mmHg | 154.4 ± 0.8 | 141.4 ± 0.6* | 144.0 ± 0.6* |
Amplitude, mmHg | 13.6 ± 1.1 | 6.3 ± 0.9* | 7.0 ± 0.8* |
Acrophase, h | 20.5 ± 0.6 | 20.2 ± 0.4 | 21.7 ± 0.5 |
Data are presented at means ± SE; n, no. of rats. MESOR, amplitude of day/night cycle, and acrophase were derived from hourly averages of 24-h recordings of mean arterial pressure at baseline (protocol day −1) 2 wk after treatment (protocol day 14).
P < 0.05 vs. time-matched Sham; one-way ANOVA with Bonferroni post hoc test.